These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29679991)

  • 61. Psychotic symptoms and neurocognition among patients with major depressive disorder: A chained mediation model of depressive symptoms and socio-occupational functioning.
    Zeng Y; Zhang F; Liu H; Li W; Ning Y; Zhou Y
    J Affect Disord; 2023 Jul; 332():194-200. PubMed ID: 37044284
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Profile of cognitive deficits and associations with depressive symptoms and intelligence in chronic early-onset schizophrenia patients.
    Jepsen JR; Fagerlund B; Pagsberg AK; Christensen AM; Nordentoft M; Mortensen EL
    Scand J Psychol; 2013 Oct; 54(5):363-70. PubMed ID: 23786210
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of cognitive deficits among drug-naive patients with schizophrenia and major depressive disorder.
    Hsu SE; Chen KC; Lee LT; Tsai HC; Lee IH; Chen PS; Yang YK
    J Affect Disord; 2015 Apr; 175():133-8. PubMed ID: 25616072
    [TBL] [Abstract][Full Text] [Related]  

  • 64. From cognitive and clinical substrates to functional profiles: Disentangling heterogeneity in schizophrenia.
    Bosia M; Bechi M; Bosinelli F; Politi E; Buonocore M; Spangaro M; Bianchi L; Cocchi F; Guglielmino C; Cavallaro R
    Psychiatry Res; 2019 Jan; 271():446-453. PubMed ID: 30537667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neurocognitive insight and objective cognitive functioning in schizophrenia.
    Burton CZ; Harvey PD; Patterson TL; Twamley EW
    Schizophr Res; 2016 Mar; 171(1-3):131-6. PubMed ID: 26811232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognitive impairment in euthymic major depressive disorder: a meta-analysis.
    Bora E; Harrison BJ; Yücel M; Pantelis C
    Psychol Med; 2013 Oct; 43(10):2017-26. PubMed ID: 23098294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction.
    Healey KM; Penn DL; Perkins D; Woods SW; Keefe RSE; Addington J
    Schizophr Bull; 2018 Feb; 44(2):286-296. PubMed ID: 29036587
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities.
    Jensen JH; Knorr U; Vinberg M; Kessing LV; Miskowiak KW
    J Affect Disord; 2016 Nov; 205():378-386. PubMed ID: 27573491
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Associations of metacognition with symptoms, insight, and neurocognition in clinically stable outpatients with schizophrenia.
    Nicolò G; Dimaggio G; Popolo R; Carcione A; Procacci M; Hamm J; Buck KD; Pompili E; Buccione I; Lagrotteria B; Lysaker PH
    J Nerv Ment Dis; 2012 Jul; 200(7):644-7. PubMed ID: 22759945
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence for specific cognitive deficits in visual information processing in patients with OCD compared to patients with unipolar depression.
    Rampacher F; Lennertz L; Vogeley A; Schulze-Rauschenbach S; Kathmann N; Falkai P; Wagner M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):984-91. PubMed ID: 20472013
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition.
    Ayesa-Arriola R; Setién-Suero E; Neergaard KD; Belzunces ÀA; Contreras F; van Haren NEM; Crespo-Facorro B
    Schizophr Res; 2018 Jul; 197():370-377. PubMed ID: 29275855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of neurocognitive domains in patients with schizophrenia with and without co-morbid obsessive compulsive disorder.
    Sahoo S; Grover S; Nehra R
    Schizophr Res; 2018 Nov; 201():151-158. PubMed ID: 29858040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia.
    Peña J; Ibarretxe-Bilbao N; Sánchez P; Uriarte JJ; Elizagarate E; Gutierrez M; Ojeda N
    J Psychiatr Res; 2018 Jun; 101():21-27. PubMed ID: 29525739
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
    Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
    J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Meta-analysis of neurocognition in young psychosis patients with current cannabis use.
    Bogaty SER; Lee RSC; Hickie IB; Hermens DF
    J Psychiatr Res; 2018 Apr; 99():22-32. PubMed ID: 29407284
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills?
    Moritz S; Klein JP; Desler T; Lill H; Gallinat J; Schneider BC
    Psychol Med; 2017 Nov; 47(15):2602-2612. PubMed ID: 28485257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cognitive predictors of illness course at 12 months after first-episode of depression.
    Vicent-Gil M; Keymer-Gausset A; Serra-Blasco M; Carceller-Sindreu M; de Diego-Adeliño J; Trujols J; Mur M; Pérez V; Alvarez E; Cardoner N; Portella MJ
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):529-537. PubMed ID: 29482974
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distinct Polygenic Score Profiles in Schizophrenia Subgroups With Different Trajectories of Cognitive Development.
    Dickinson D; Zaidman SR; Giangrande EJ; Eisenberg DP; Gregory MD; Berman KF
    Am J Psychiatry; 2020 Apr; 177(4):298-307. PubMed ID: 31838871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.